TNYA — Tenaya Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00- $338.41m
- $233.77m
- 35
- 18
- 62
- 32
Annual cashflow statement for Tenaya Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -26.2 | -38.4 | -72.7 | -124 | -124 |
| Depreciation | |||||
| Non-Cash Items | 0.396 | 0.699 | 4.21 | 13.6 | 19 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.25 | -0.234 | 4.74 | -0.849 | -5.65 |
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -24.1 | -35.4 | -60.8 | -104 | -102 |
| Capital Expenditures | -2.93 | -9.76 | -25.1 | -20.6 | -1.24 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -2.66 | 2.75 | -213 | 104 | 50 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -5.58 | -7.01 | -239 | 83.7 | 48.7 |
| Financing Cash Flow Items | — | — | 0.087 | 0 | 3.37 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 30.5 | 147 | 209 | 77.8 | 4.05 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.832 | 105 | -90.4 | 57 | -49.3 |